Company Overview of Eurofarma Laboratórios S.A.
Eurofarma Laboratórios S.A. produces and markets medical prescription, veterinary, and over-the-counter drugs. It also offers medicines for hospital use, which include antibiotics, anesthetics, antifungals, antivirals, uterine stimulants, exchange resins, anti-ulcer, anti-inflammatory, and anticoagulant drugs; and serums in bags and jars. In addition, the company provides antiparasitic, vitamins, and tonics for the prevention and treatment of diseases primarily in cattle; and oncology drugs. Further, it manufactures medicines of various therapeutic classes and in various dosage forms, including cosmetics and hygiene products to other laboratories. Further, the company offers ampoules and via...
Av. Vereador José Diniz, nº 3465
São Paulo, SP 04603-003
Founded in 1972
Key Executives for Eurofarma Laboratórios S.A.
Eurofarma Laboratórios S.A. does not have any Key Executives recorded.
Eurofarma Laboratórios S.A. Key Developments
Melinta Therapeutics, Inc. Partners with Eurofarma Laboratorios S.A
Jan 12 15
Melinta Therapeutics, Inc. and Eurofarma Laboratorios S.A. have entered into commercialization and distribution agreements for delafloxacin, an investigational fluoroquinolone. Under the terms of the agreements, Eurofarma will be responsible for obtaining regulatory approval in Brazil and will then have the right to market, sell and distribute delafloxacin in that country for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Melinta will receive a combined upfront cash and equity payment of $15 million, as well as milestones and royalties on future sales of delafloxacin.
Eurofarma Seeks Acquisitions In Mexico And Latin America
Feb 12 14
Eurofarma Laboratorios Ltda. is looking for acquisitions opportunities. Maria Del Pilar Muñoz Director of Eurofarma said that Eurofarma aims to have established operations in Mexico and the second largest market in Latin America by 2015. It is planning to acquire 90% share of the Latin American pharmaceutical market, in which it has 70% share.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries